South Korea's SK Telecom dives into China's medtech industry

American companies aren't the only ones trying to jump into China's surging medical device and healthcare market. SK Telecom in South Korea is the latest to take the plunge and Dow Jones reports that, in a bid to diversify its portfolio, SK will become the second-largest shareholder of China's Xi'an Tianlong Science and Technology Co. Xi'an Tianlong makes medical diagnostics equipment, according to the article. Story

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.